Sage Therapeutic
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $11,871 | $8,654 | $7,902 | $77,972 |
Gross Profit | 6,593 | 7,247 | 6,633 | 77,152 |
EBITDA | -101,202 | -110,989 | -116,742 | -42,091 |
EBIT | -111,300 | -117,078 | -42,500 | |
Net Income | -93,551 | -102,854 | -108,483 | -32,706 |
Net Change In Cash | 11,871 | 8,654 | 7,902 | 77,972 |
Free Cash Flow | -82,365 | -80,437 | -37,832 | -119,407 |
Cash | 99,627 | 101,233 | 173,985 | 70,992 |
Basic Shares | 61,116 | 60,538 | 60,136 | 59,990 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $86,455 | $7,686 | $6,308 | $1,114,200 |
Gross Profit | 84,296 | 6,873 | 5,755 | 1,113,635 |
EBITDA | -511,684 | -545,867 | -456,727 | 651,712 |
EBIT | -513,077 | -546,989 | -460,909 | 649,082 |
Net Income | -541,489 | -503,267 | -450,827 | 606,073 |
Net Change In Cash | 86,455 | 7,686 | 6,308 | 1,114,200 |
Cost of Revenue | -131,533 | -1,367,296 | 1,533,726 | |
Free Cash Flow | -541,138 | -460,973 | -378,554 | 663,935 |
Cash | 70,992 | 162,700 | 294,233 | 1,661,082 |
Basic Shares | 59,836 | 59,306 | 58,670 | 53,003 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.53 |
2024-06-30 | -$1.70 |
2024-03-31 | -$1.80 |
2023-12-31 | -$1.80 |
